Onconova Therapeutics
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12 Penns Trl, Newtown, Pennsylvania, 189...Phone Number
(267) 759-3680Website
www.onconova.comRevenue
<$5 MillionStock Symbol
ONTXIndustry
About Onconova Therapeutics
Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel drugs to treat cancer. Onconova has a pipeline of proprietary targeted agents designed to work against specific cellular pathways that are important in cancer cells. Clinical trials with the Company's compound rigosertib are aimed at what the Company believes are unmet medical needs of patients with cancer. Onconova has conducted trials with two other research compounds, and has a pre-clinical program with a CDK4/6 and ARK5 inhibitor, ON 123300.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: ONTXShow moreOnconova Therapeutics Org Chart
Compare Similar Companies to Onconova Therapeutics
Compare insights from companies similar to Onconova Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
1-10
Public
$185.6M
2016
Allan MussoChief Financial Officer & Principal Financial Officer and Principal Accounting Officer
Onconova Therapeutics Tech Stack
A closer look at the technologies used by Onconova Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Onconova Therapeutics
Sign Up For FreeTo access detailed company insights
Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel drugs to treat cancer. Onconova has a pipeline of proprietary targeted agents designed to work against specific cellular pathways that are important in cancer cells. Clinical trials with the Company's compound rigosertib are aimed at what the Company be... Read More